Pretherapeutic detection of tumour resistance and the results of tumour chemotherapy.
about
Prediction of Cancer Drug Resistance and Implications for Personalized MedicineCD133 is indicative for a resistance phenotype but does not represent a prognostic marker for survival of non-small cell lung cancer patientsIn vivo-like drug responses of human tumors growing in three-dimensional gel-supported primary culture.Relationship between chemoresistance of lung tumours and cigarette smoking.A comparison of three assays used for the in vitro chemosensitivity testing of human tumours.The response of tumour cells to radiation and cytotoxic drugs--a comparison of clonogenic and isotope uptake assaysOverexpression of P-glycoprotein and glutathione S-transferase-pi in resistant non-small cell lung carcinomas of smokers.Occurrence of a multidrug-resistant phenotype in human lung xenograftsAn assessment of a short-term tumour chemosensitivity assay in chronic lymphocytic leukaemia.Protein expression profiles indicative for drug resistance of non-small cell lung cancerIn vitro evaluation of chemotherapeutic agents.In vitro drug sensitivity of tumor cells is correlated with drug-induced inhibition of DNA synthesis.Drug sensitivity testing of human breast cancer.Studying lung cancer in the laboratory--2: Chemosensitivity testing.Stability of solutions of antineoplastic agents during preparation and storage for in vitro assays. General considerations, the nitrosoureas and alkylating agents.Predictive testing in cancer chemotherapy. II. In vitro.Predictive tests in cancer chemotherapy. A reappraisal.Clinical value of in vitro drug sensitivity testing based on short-term effects on DNA and RNA metabolism in ovarian cancer.Relationship of DNA ploidy to chemoresistance of tumors as measured by in vitro tests.Prediction of the clinical chemotherapeutic response of stage III lung adenocarcinoma patients by an in vitro short term test.Predictive chemosensitivity testing.Comparative studies of chemotherapy of human tumor cells in vitro by tritiated thymidine uptake inhibition and soft agar clonogenic assay.Prognostic significance of DNA patterns and resistance-predictive tests in non-small cell lung carcinoma.Cisplatin chemotherapy of ovarian cancer: is short-term in vitro chemosensitivity predictive of long-term patient survival?DNA analysis, chemoresistance testing and hormone receptor levels as prognostic factors in advanced ovarian carcinoma.Correlations between natural resistance to doxorubicin, proliferative activity, and expression of P-glycoprotein 170 in human kidney tumor cell lines.DNA distribution in non-small-cell lung carcinomas and its relationship to clinical behavior.Rapid assay for the in vitro chemosensitivity testing of human breast tumours. Control of assay conditions and quality assurance.Application of the MTT assay to human prostate cancer cell lines in vitro: establishment of test conditions and assessment of hormone-stimulated growth and drug-induced cytostatic and cytotoxic effects.In vitro chemosensitivity testing of leukemic cells: prediction of response to chemotherapy in patients with acute non-lymphocytic leukemia.The Panje button.Tissue-factor expression in human non-small-cell lung carcinoma measured by immunohistochemistry: correlation between tissue factor and angiogenesis.Relationship of inherent resistance to doxorubicin, proliferative activity and expression of P-glycoprotein 170, and glutathione S-transferase-pi in human lung tumors.Reliability of an in vitro short-term assay to predict the drug sensitivity of human breast cancer.In vitro determination of tumour chemosensitivity in haematological malignancies.Prediction of the response to chemotherapy in acute leukemia by a short-term test in vitro.Multidrug-Resistenz von Tumoren
P2860
Q26770581-8048AFAC-CE9E-4F4A-850F-B04173CDD679Q28254772-8E95762C-83D9-455D-9C59-19FD0FCD713CQ34640882-E09298F0-E6B2-4E6E-B347-C861C134B6F2Q35983127-B749FE8C-C45E-4A63-90DA-94B2F251D6BEQ35991247-F3DB4619-8D0E-4940-A9F2-5D97DCA9B297Q35991995-C4D60D47-2B7A-47E7-9A1A-0C75E107E692Q35993861-E0208208-46C3-400E-B8DE-FE5262289A44Q36028312-2FDAE3E3-66B6-4570-B205-AF30094DE273Q36047694-BDA1E0C6-F227-4211-A1E5-DE34EF844CB2Q36623993-950E3F17-56B7-454B-8B50-C815942CADB6Q36810391-2B37F478-38C4-4DF7-8CDD-8543497FB3E2Q36988697-49F3F217-23B6-4921-B2F6-2C6387A28569Q37938307-B0EC93A9-AC5E-4ADE-A4FA-FFC78E2988C5Q39688552-EA7009E8-C6E1-4ED0-9E95-A955853228E4Q39814611-BF7A13E2-FB19-4BBA-BCEC-81DB9BD9A8C4Q39830563-B082A5BE-5022-4879-9DEB-7A1C5621BCB5Q40175495-04C3652A-9C0C-47C7-B5B9-729FF69B61BDQ41315677-56B30801-4734-46DA-A2A4-3B0081265F50Q41756303-2C936D2A-E479-4E93-B9C3-D14AD0ADAFCDQ41927174-81A98F0E-CA11-477D-AC73-B3B86D48231DQ42374199-96FC1A50-E00B-4BE4-AB4A-EDE3F14D1069Q43707318-894574E2-FE04-4038-B873-AF8EAD6E3CA7Q43869257-E7CD6337-D020-442D-AC26-32C8BC0DC018Q44638601-FD984A39-39D3-47F7-989D-7F92624CF5D3Q44743154-FFE89EB4-AA1B-4EB0-B954-2E4AA7098D3FQ44829816-5FDA0CBA-9122-4DED-820E-430C08465B8BQ45765064-5CCBC9EC-A96A-477B-B1C0-7B1AEB3AF2FFQ50885348-E63B06C6-E3F9-42C8-A921-6B7CDB207815Q50899140-5CD95549-8A74-4A18-BC5B-0014AAF074A9Q53514464-1A398FC7-C314-45FD-BF90-1EA6FA471D64Q53564896-DA40EB22-BD1B-4A1B-AB70-DCF09C8468D7Q54145263-E32C693C-BA5B-451D-80E5-C89E15ADCB0CQ54264267-BC540332-9765-4868-8E45-67D10DFF58B6Q54446133-9C20B98E-B39D-4B23-9511-1E22398F82EEQ54462842-11FA4AE7-F011-4AD5-8B81-DBFC693D6D11Q54480068-BC68D6F4-6C5C-457E-9112-B28280590601Q58598467-88922C08-B3A5-494E-B1A3-DAE43E91DB2E
P2860
Pretherapeutic detection of tumour resistance and the results of tumour chemotherapy.
description
1979 nî lūn-bûn
@nan
1979年の論文
@ja
1979年学术文章
@wuu
1979年学术文章
@zh-cn
1979年学术文章
@zh-hans
1979年学术文章
@zh-my
1979年学术文章
@zh-sg
1979年學術文章
@yue
1979年學術文章
@zh
1979年學術文章
@zh-hant
name
Pretherapeutic detection of tumour resistance and the results of tumour chemotherapy.
@en
Pretherapeutic detection of tumour resistance and the results of tumour chemotherapy.
@nl
type
label
Pretherapeutic detection of tumour resistance and the results of tumour chemotherapy.
@en
Pretherapeutic detection of tumour resistance and the results of tumour chemotherapy.
@nl
prefLabel
Pretherapeutic detection of tumour resistance and the results of tumour chemotherapy.
@en
Pretherapeutic detection of tumour resistance and the results of tumour chemotherapy.
@nl
P2093
P1476
Pretherapeutic detection of tumour resistance and the results of tumour chemotherapy.
@en
P2093
P304
P356
10.1016/0014-2964(79)90282-2
P577
1979-07-01T00:00:00Z